U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis ...

Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial ...

Takeda ( TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize ...

Keros Therapeutics, Inc. has announced a significant global license agreement with Takeda for the advancement of elritercept, ...

The Ohio State University College of Nursing and the Ohio State Wexner Medical Center developed a new blood test that can ...

Children with learning or developmental difficulties are at higher risk of exposure to lead. The UK Health Security Agency's ...

indicating that the development of anemia is independent from nutritional factors. The present study is limited by a relative small number of patients. For future investigations, larger study ...

By looking out for these red-flag signs regularly, you could possibly avoid a harrowing diagnosis and seek treatment early ...

Dr Karan Raj has shared a video on TikTok, explaining three health signs you should never ignore - and one of them is ...

HbA1c tests provide an average indication of blood sugar control over the past 2-3 months, which helps in managing diabetes ...

Clinical data include analyses of novel, investigational therapies with the potential to help address unmet needs in sickle cell disease and hemophiliaNew data from the HIBISCUS phase 2 trial ...